Pfizer eyes big drop in COVID-related revenues in 2023
After two straight years of surging sales due to COVID-19 products, Pfizer projected a steep decline in 2023 revenues as demand for vaccines and therapeutics ebbs.
Jan 31, 2023
0
57
MeSH tree: D12.776.828
After two straight years of surging sales due to COVID-19 products, Pfizer projected a steep decline in 2023 revenues as demand for vaccines and therapeutics ebbs.
Jan 31, 2023
0
57
A booster (third) dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses, according to a new study from Hong Kong published in CMAJ (Canadian ...
Jan 30, 2023
0
57
Scientists have found the "booster" COVID-19 vaccine program led to a large boost in the antibodies that help protect against coronavirus. High levels of antibodies is associated with lower risk of severe infection.
Jan 24, 2023
0
51
A team of researchers at FAU and Universitätsklinikum Erlangen has gained new insights into the maturation of SARS-CoV-specific antibodies after multiple vaccinations with the Comirnaty mRNA vaccine. They have now published ...
Jan 9, 2023
0
66
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
138
Researchers at the AIDS Institute, Department of Microbiology, School of Clinical Medicine, and the State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) reveals ...
Jan 4, 2023
0
137
The first reports that several women experienced menstrual disturbances after coronavirus vaccination came early in summer 2021. The Norwegian Institute of Public Health (NIPH) promptly introduced questions about menstrual ...
Dec 19, 2022
0
124
Less known to the general public, mucosal vaccination via the mucus membranes could provide robust protection against SARS-CoV-2 infections. Immune cells in the nose and lungs are considered better prepared to encounter and ...
Dec 16, 2022
0
54
Adult hospitalizations from omicron-related SARS-CoV-2 (COVID-19) were less severe than delta and the Pfizer-BioNTech vaccine (also known as Comirnaty and BNT162b2) remains effective in preventing not only hospitalization, ...
Dec 13, 2022
0
74
Moderna's stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.
Dec 13, 2022
0
43